As per corporate shareholdings filed for Jul-2025, people matching LC publicly holds 140 stocks with a net worth of over US$ 17.0 B.
These are shares held by LC as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.
| Stock Name | Holders Name | Current Price US$ | Quantity Held | Holding Percent | Change from Previous Qtr | Holding Value US$ | History | |
|---|---|---|---|---|---|---|---|---|
| Enanta Pharmaceuticals Inc | Farallon Capital Management, L.L.C. | 8.28 | 2,122,262 | 9.93% | 0.00 | 17.6 M | ||
| Agios Pharmaceuticals Inc | Farallon Capital Management, L.L.C. | 36.78 | 5,767,466 | 9.93% | 0.12 | 212.1 M | ||
| Protagonist Therapeutics Inc | Farallon Capital Management, L.L.C. | 58.86 | 6,172,006 | 9.92% | 0.10 | 363.3 M | ||
| Beam Therapeutics Inc | Farallon Capital Management, L.L.C. | 20.60 | 10,013,111 | 9.90% | 0.08 | 206.3 M | ||
| Lantheus Holdings Inc | Farallon Capital Management, L.L.C. | 52.94 | 6,722,227 | 9.89% | 1.03 | 355.9 M | ||
| Beta Bionics Inc. | Farallon Capital Management, L.L.C. | 26.41 | 4,203,920 | 9.67% | 2.01 | 111.0 M | ||
| Tango Therapeutics Inc | Farallon Capital Management, L.L.C. | 6.53 | 9,157,000 | 8.23% | 4.09 | 59.8 M | ||
| Longboard Pharmaceuticals Inc | Farallon Capital Management, L.L.C. | 59.98 | 3,150,857 | 8.07% | 0.00 | 189.0 M | ||
| Revolution Medicines Inc | Farallon Capital Management, L.L.C. | 46.55 | 14,325,692 | 7.66% | 0.42 | 666.9 M | ||
| Exelixis Inc | Farallon Capital Management, L.L.C. | 39.15 | 16,035,500 | 5.96% | -2.41 | 627.8 M | ||
| Crinetics Pharmaceuticals Inc | Farallon Capital Management, L.L.C. | 34.00 | 4,646,098 | 4.93% | 0.04 | 158.0 M | ||
| Liquidia Corp | Farallon Capital Management, L.L.C. | 25.99 | 4,238,762 | 4.92% | 0.29 | 110.2 M | ||
| Aramark | Farallon Capital Management, L.L.C. | 38.47 | 12,899,701 | 4.91% | -1.27 | 496.3 M | ||
| Tectonic Therapeutic Inc. | Farallon Capital Management, L.L.C. | 17.72 | 853,050 | 4.56% | 0.00 | 15.1 M | ||
| BridgeBio Pharma Inc | Farallon Capital Management, L.L.C. | 51.21 | 7,900,000 | 4.13% | 1.13 | 404.6 M | ||
| Savara Inc | Farallon Capital Management, L.L.C. | 3.56 | 6,835,000 | 3.95% | 0.00 | 24.3 M | ||
| Ambrx Biopharma Inc - ADR | Farallon Capital Management, L.L.C. | 0.00 | 2,269,000 | 3.66% | 0.00 | - | ||
| Hims & Hers Health Inc - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 55.50 | 8,213,581 | 3.63% | 0.11 | 455.9 M | ||
| Natera Inc | Farallon Capital Management, L.L.C. | 168.51 | 4,821,809 | 3.51% | 0.20 | 812.5 M | ||
| New York Times Co. - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 58.93 | 5,609,546 | 3.45% | -2.04 | 330.6 M | ||
| Centessa Pharmaceuticals plc - ADR | Farallon Capital Management, L.L.C. | 21.81 | 4,529,318 | 3.38% | 0.15 | 98.8 M | ||
| Forest Road Acquisition Corp II - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 10.43 | 400,000 | 3.02% | 0.00 | 4.2 M | ||
| TransUnion | Farallon Capital Management, L.L.C. | 91.72 | 5,404,575 | 2.77% | 0.00 | 495.7 M | ||
| Arya Sciences Acquisition Corp IV - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 5.20 | 200,000 | 2.65% | 0.00 | 1.0 M | ||
| Helix Acquisition Corp. II - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 10.39 | 600,000 | 2.55% | 0.00 | 6.2 M | ||
| IQVIA Holdings Inc | Farallon Capital Management, L.L.C. | 187.22 | 3,851,351 | 2.27% | 0.26 | 721.0 M | ||
| Tyra Biosciences Inc | Farallon Capital Management, L.L.C. | 12.52 | 1,143,818 | 2.15% | 0.00 | 14.3 M | ||
| Verona Pharma Plc - ADR | Farallon Capital Management, L.L.C. | 106.43 | 1,810,000 | 2.09% | 0.84 | 192.6 M | ||
| Ares Acquisition Corporation - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 10.79 | 1,425,000 | 2.02% | 0.00 | 15.4 M | ||
| JOYY Inc - ADR | Farallon Capital Management, L.L.C. | 62.53 | 787,906 | 1.53% | 0.03 | 49.3 M | ||
| Woodward Inc | Farallon Capital Management, L.L.C. | 238.17 | 914,673 | 1.53% | -0.84 | 217.8 M | ||
| Schrodinger Inc | Farallon Capital Management, L.L.C. | 18.57 | 1,106,000 | 1.50% | NEW | 20.5 M | ||
| Surgery Partners Inc | Farallon Capital Management, L.L.C. | 21.87 | 1,926,000 | 1.50% | NEW | 42.1 M | ||
| Mirati Therapeutics Inc | Farallon Capital Management, L.L.C. | 58.70 | 1,001,000 | 1.43% | 0.00 | 58.8 M | ||
| GRAIL Inc. | Farallon Capital Management, L.L.C. | 38.04 | 502,000 | 1.39% | NEW | 19.1 M | ||
| Marblegate Acquisition Corp - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 36.05 | 150,000 | 1.30% | 0.00 | 5.4 M | ||
| Voyager Therapeutics Inc | Farallon Capital Management, L.L.C. | 4.18 | 715,000 | 1.29% | -3.35 | 3.0 M | ||
| UTA Acquisition Corp. - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 10.67 | 344,100 | 1.20% | 0.00 | 3.7 M | ||
| Reata Pharmaceuticals Inc - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 172.36 | 451,700 | 1.19% | 0.00 | 77.9 M | ||
| GeneDx Holdings Corp - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 123.95 | 326,677 | 1.14% | 0.08 | 40.5 M | ||
| VNET Group Inc - ADR | Farallon Capital Management, L.L.C. | 9.57 | 2,994,120 | 1.11% | 0.21 | 28.7 M | ||
| Screaming Eagle Acquisition Corp - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 10.18 | 1,000,000 | 1.07% | 0.00 | 10.2 M | ||
| Verve Therapeutics Inc | Farallon Capital Management, L.L.C. | 11.13 | 912,000 | 1.02% | 0.00 | 10.2 M | ||
| Ultragenyx Pharmaceutical Inc. | Farallon Capital Management, L.L.C. | 30.31 | 898,000 | 0.93% | NEW | 27.2 M | ||
| Aon plc. - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 371.95 | 1,986,417 | 0.92% | 0.29 | 738.8 M | ||
| Autodesk Inc. | Farallon Capital Management, L.L.C. | 319.04 | 1,744,652 | 0.82% | -0.11 | 556.6 M | ||
| Cidara Therapeutics Inc | Farallon Capital Management, L.L.C. | 65.62 | 200,000 | 0.79% | NEW | 13.1 M | ||
| Westinghouse Air Brake Technologies Corp | Farallon Capital Management, L.L.C. | 188.82 | 1,308,198 | 0.77% | -0.18 | 247.0 M | ||
| Nasdaq Inc - Ordinary Shares - 144A | Farallon Capital Management, L.L.C. | 93.95 | 4,083,743 | 0.71% | -0.07 | 383.7 M | ||
| CBRE Group Inc - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 164.02 | 2,113,138 | 0.71% | -0.13 | 346.6 M | ||
| New Oriental Education & Technology Group Inc. - ADR | Farallon Capital Management, L.L.C. | 53.74 | 1,155,150 | 0.71% | -0.09 | 62.1 M | ||
| Encompass Health Corp | Farallon Capital Management, L.L.C. | 126.05 | 708,000 | 0.70% | 0.09 | 89.2 M | ||
| Tenet Healthcare Corp. | Farallon Capital Management, L.L.C. | 192.82 | 529,000 | 0.60% | NEW | 102.0 M | ||
| Oscar Health Inc - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 19.33 | 1,476,000 | 0.57% | 0.57 | 28.5 M | ||
| Summit Midstream Partners LP - Unit | Farallon Capital Management, L.L.C. | 23.35 | 58,214 | 0.55% | 0.00 | 1.4 M | ||
| Summit Midstream Corp. | Farallon Capital Management, L.L.C. | 23.35 | 58,214 | 0.48% | 0.00 | 1.4 M | ||
| Tvardi Therapeutics Inc. | Farallon Capital Management, L.L.C. | 33.88 | 43,225 | 0.46% | 0.22 | 1.5 M | ||
| Prime Medicine Inc | Farallon Capital Management, L.L.C. | 4.07 | 750,000 | 0.42% | 0.00 | 3.1 M | ||
| Alkermes plc | Farallon Capital Management, L.L.C. | 26.97 | 691,663 | 0.42% | -0.42 | 18.7 M | ||
| Healthequity Inc | Farallon Capital Management, L.L.C. | 92.49 | 319,800 | 0.37% | -0.12 | 29.6 M | ||
| Thermo Fisher Scientific Inc. | Farallon Capital Management, L.L.C. | 479.46 | 1,383,241 | 0.37% | 0.09 | 663.2 M | ||
| Chindata Group Holdings Ltd - ADR | Farallon Capital Management, L.L.C. | 0.00 | 1,300,000 | 0.35% | 0.00 | - | ||
| Waystar Holding Corp | Farallon Capital Management, L.L.C. | 37.36 | 613,000 | 0.35% | -0.81 | 22.9 M | ||
| GE HealthCare Technologies Inc | Farallon Capital Management, L.L.C. | 76.44 | 1,322,000 | 0.29% | 0.17 | 101.1 M | ||
| Walt Disney Co (The) | Farallon Capital Management, L.L.C. | 115.96 | 4,874,268 | 0.27% | -0.03 | 565.2 M | ||
| Boston Scientific Corp. | Farallon Capital Management, L.L.C. | 102.71 | 3,981,057 | 0.27% | 0.01 | 408.9 M | ||
| Analog Devices Inc. | Farallon Capital Management, L.L.C. | 245.21 | 1,272,200 | 0.26% | -0.01 | 312.0 M | ||
| Mckesson Corporation | Farallon Capital Management, L.L.C. | 711.42 | 314,600 | 0.25% | -0.19 | 223.8 M | ||
| Marathon Digital Holdings Inc | Farallon Capital Management, L.L.C. | 16.31 | 835,000 | 0.23% | 0.00 | 13.6 M | ||
| Salesforce Inc | Farallon Capital Management, L.L.C. | 242.76 | 2,109,110 | 0.22% | 0.02 | 512.0 M | ||
| Charles Schwab Corp. | Farallon Capital Management, L.L.C. | 93.54 | 3,959,057 | 0.22% | 0.01 | 370.3 M | ||
| Nuvalent Inc - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 80.47 | 150,000 | 0.21% | 0.00 | 12.1 M | ||
| AleAnna Inc. - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 4.38 | 78,400 | 0.19% | 0.00 | 343.4 K | ||
| Intuit Inc | Farallon Capital Management, L.L.C. | 646.03 | 536,658 | 0.19% | -0.11 | 346.7 M | ||
| Mr. Cooper Group Inc | Farallon Capital Management, L.L.C. | 220.35 | 122,500 | 0.19% | NEW | 27.0 M | ||
| Cardinal Health, Inc. | Farallon Capital Management, L.L.C. | 152.24 | 454,000 | 0.19% | 0.08 | 69.1 M | ||
| Unitedhealth Group Inc | Farallon Capital Management, L.L.C. | 352.51 | 1,617,300 | 0.18% | 0.01 | 570.1 M | ||
| SpringWorks Therapeutics Inc | Farallon Capital Management, L.L.C. | 46.99 | 118,000 | 0.16% | 0.00 | 5.5 M | ||
| Globus Medical Inc - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 58.74 | 210,000 | 0.16% | 0.09 | 12.3 M | ||
| Full Truck Alliance Co Ltd - ADR | Farallon Capital Management, L.L.C. | 13.62 | 1,550,598 | 0.15% | -0.56 | 21.1 M | ||
| LATAM Airlines Group S.A. - ADR | Farallon Capital Management, L.L.C. | 48.39 | 318,092 | 0.11% | -0.08 | 15.4 M | ||
| Flutter Entertainment Plc | Farallon Capital Management, L.L.C. | 281.09 | 181,229 | 0.10% | -0.04 | 50.9 M | ||
| Capricor Therapeutics Inc | Farallon Capital Management, L.L.C. | 6.36 | 41,000 | 0.09% | -4.83 | 260.8 K | ||
| Biodesix Inc | Farallon Capital Management, L.L.C. | 0.38 | 128,000 | 0.09% | -1.18 | 48.6 K | ||
| Janux Therapeutics Inc | Farallon Capital Management, L.L.C. | 24.05 | 48,000 | 0.08% | 0.00 | 1.2 M | ||
| Sage Therapeutics Inc | Farallon Capital Management, L.L.C. | 8.68 | 42,800 | 0.07% | 0.00 | 371.5 K | ||
| Pacific Biosciences of California Inc | Farallon Capital Management, L.L.C. | 1.17 | 135,000 | 0.04% | 0.00 | 158.0 K | ||
| C4 Therapeutics Inc | Farallon Capital Management, L.L.C. | 2.66 | 28,000 | 0.04% | 0.00 | 74.5 K | ||
| Altimmune Inc | Farallon Capital Management, L.L.C. | 3.64 | 27,600 | 0.03% | 0.00 | 100.5 K | ||
| Amazon.com Inc. | Farallon Capital Management, L.L.C. | 228.15 | 3,034,600 | 0.03% | NEW | 692.3 M | ||
| uniQure N.V. | Farallon Capital Management, L.L.C. | 16.48 | 14,000 | 0.03% | 0.00 | 230.7 K | ||
| Beyond Meat Inc | Farallon Capital Management, L.L.C. | 2.68 | 19,000 | 0.02% | 0.00 | 50.9 K | ||
| Microsoft Corporation | Farallon Capital Management, L.L.C. | 509.90 | 1,747,835 | 0.02% | -0.01 | 891.2 M | ||
| Arcutis Biotherapeutics Inc | Farallon Capital Management, L.L.C. | 17.29 | 26,000 | 0.02% | 0.00 | 449.5 K | ||
| Progyny Inc | Farallon Capital Management, L.L.C. | 22.51 | 18,000 | 0.02% | 0.00 | 405.2 K | ||
| Mastercard Incorporated - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 580.41 | 152,071 | 0.02% | -0.01 | 88.3 M | ||
| Visa Inc - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 339.43 | 308,810 | 0.02% | -0.01 | 104.8 M | ||
| Madrigal Pharmaceuticals Inc | Farallon Capital Management, L.L.C. | 432.22 | 3,319 | 0.01% | 0.00 | 1.4 M | ||
| Alphabet Inc - Ordinary Shares - Class C | Farallon Capital Management, L.L.C. | 241.38 | 1,761,840 | 0.01% | 0.00 | 425.3 M | ||
| Travere Therapeutics Inc | Farallon Capital Management, L.L.C. | 23.47 | 12,000 | 0.01% | NEW | 281.6 K | ||
| Twist Bioscience Corp | Farallon Capital Management, L.L.C. | 25.31 | 7,650 | 0.01% | 0.00 | 193.6 K | ||
| BrightSpring Health Services Inc | Farallon Capital Management, L.L.C. | 26.45 | 22,000 | 0.01% | 0.00 | 581.9 K | ||
| Cogent Biosciences Inc | Farallon Capital Management, L.L.C. | 12.66 | 17,000 | 0.01% | 0.00 | 215.2 K | ||
| Evolent Health Inc - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 9.02 | 14,000 | 0.01% | 0.00 | 126.3 K | ||
| Syndax Pharmaceuticals Inc | Farallon Capital Management, L.L.C. | 15.55 | 10,000 | 0.01% | 0.00 | 155.5 K | ||
| Arrowhead Pharmaceuticals Inc. | Farallon Capital Management, L.L.C. | 29.72 | 15,800 | 0.01% | 0.00 | 469.6 K | ||
| LivaNova PLC | Farallon Capital Management, L.L.C. | 56.22 | 6,000 | 0.01% | -0.06 | 337.3 K | ||
| Cg Oncology Inc. | Farallon Capital Management, L.L.C. | 33.34 | 8,000 | 0.01% | NEW | 266.7 K | ||
| Novavax, Inc. | Farallon Capital Management, L.L.C. | 7.98 | 16,000 | 0.01% | 0.00 | 127.7 K | ||
| Canopy Growth Corporation | Farallon Capital Management, L.L.C. | 1.37 | 30,000 | 0.01% | 0.00 | 41.1 K | ||
| Ardelyx Inc | Farallon Capital Management, L.L.C. | 6.61 | 23,000 | 0.01% | 0.00 | 152.0 K | ||
| Soleno Therapeutics Inc | Farallon Capital Management, L.L.C. | 53.62 | 5,000 | 0.01% | 0.00 | 268.1 K | ||
| Axsome Therapeutics Inc | Farallon Capital Management, L.L.C. | 118.42 | 4,000 | 0.01% | 0.00 | 473.7 K | ||
| Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 1.31 | 13,000 | 0.01% | 0.00 | 17.0 K | ||
| Abbott Laboratories | Farallon Capital Management, L.L.C. | 133.73 | 136,000 | 0.01% | -0.01 | 18.2 M | ||
| Scholar Rock Holding Corp | Farallon Capital Management, L.L.C. | 31.67 | 7,000 | 0.01% | 0.00 | 221.7 K | ||
| Arcellx Inc | Farallon Capital Management, L.L.C. | 76.19 | 4,000 | 0.01% | 0.00 | 304.8 K | ||
| Iovance Biotherapeutics Inc | Farallon Capital Management, L.L.C. | 2.27 | 26,000 | 0.01% | 0.00 | 59.0 K | ||
| Dyne Therapeutics Inc | Farallon Capital Management, L.L.C. | 13.15 | 10,000 | 0.01% | 0.00 | 131.5 K | ||
| Krystal Biotech Inc | Farallon Capital Management, L.L.C. | 143.68 | 2,000 | 0.01% | 0.00 | 287.4 K | ||
| Immunovant Inc | Farallon Capital Management, L.L.C. | 16.16 | 12,000 | 0.01% | 0.00 | 193.9 K | ||
| Geron Corp. | Farallon Capital Management, L.L.C. | 1.27 | 43,000 | 0.01% | 0.00 | 54.6 K | ||
| Guardant Health Inc | Farallon Capital Management, L.L.C. | 54.90 | 8,000 | 0.01% | NEW | 439.2 K | ||
| Blueprint Medicines Corp | Farallon Capital Management, L.L.C. | 129.46 | 4,000 | 0.01% | 0.00 | 517.8 K | ||
| Sabra Healthcare REIT Inc | Farallon Capital Management, L.L.C. | 19.05 | 14,000 | 0.01% | 0.00 | 266.7 K | ||
| Roivant Sciences Ltd | Farallon Capital Management, L.L.C. | 14.08 | 37,000 | 0.01% | 0.00 | 521.0 K | ||
| Amicus Therapeutics Inc | Farallon Capital Management, L.L.C. | 7.99 | 16,000 | 0.01% | 0.00 | 127.8 K | ||
| Merit Medical Systems, Inc. | Farallon Capital Management, L.L.C. | 85.53 | 3,000 | 0.01% | 0.00 | 256.6 K | ||
| Akero Therapeutics Inc | Farallon Capital Management, L.L.C. | 43.46 | 4,000 | 0.01% | NEW | 173.8 K | ||
| Glaukos Corporation | Farallon Capital Management, L.L.C. | 82.76 | 2,600 | 0.00% | 0.00 | 215.2 K | ||
| Grifols SA - ADR - Level III | Farallon Capital Management, L.L.C. | 9.88 | 28,000 | 0.00% | 0.00 | 276.6 K | ||
| R1 RCM Inc. | Farallon Capital Management, L.L.C. | 52.00 | 16,000 | 0.00% | 0.00 | 832 K | ||
| Healthcare Realty Trust Inc - Ordinary Shares - Class A | Farallon Capital Management, L.L.C. | 18.34 | 12,000 | 0.00% | 0.00 | 220.1 K | ||
| Bruker Corp | Farallon Capital Management, L.L.C. | 30.91 | 5,000 | 0.00% | 0.00 | 154.6 K | ||
| Ascendis Pharma A/S - ADR | Farallon Capital Management, L.L.C. | 195.58 | 1,400 | 0.00% | 0.00 | 273.8 K | ||
| United Therapeutics Corp | Farallon Capital Management, L.L.C. | 405.02 | 1,000 | 0.00% | 0.00 | 405.0 K | ||
| Insmed Inc | Farallon Capital Management, L.L.C. | 145.93 | 3,000 | 0.00% | 0.00 | 437.8 K | ||
| BeiGene Ltd - ADR | Farallon Capital Management, L.L.C. | 324.34 | 1,100 | 0.00% | 0.00 | 356.8 K | ||
| BeiGene Ltd - ADR | Farallon Capital Management, L.L.C. | 324.34 | 1,100 | 0.00% | 0.00 | 356.8 K | ||
| Cencora Inc. | Farallon Capital Management, L.L.C. | 302.52 | 1,000 | 0.00% | 0.00 | 302.5 K |